This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Addgene
product type :
cDNA
product name :
pLenti 4.1 Ex miR200c-141
catalog :
35534
citations: 7
| Reference |
|---|
Simpson K, Conquer van Heumen G, Watson K, Roth M, Martin C, Moorehead R. Re-expression of miR-200s in claudin-low mammary tumor cells alters cell shape and reduces proliferation and invasion potentially through modulating other miRNAs and SUZ12 regulated genes. Cancer Cell Int. 2021;21:89 pubmed publisher
|
Li T, Lu H, Mukherjee D, Lahiri S, Shen C, Yu L, et al. Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer. Oncotarget. 2015;6:21428-42 pubmed
|
product information
Catalog Number :
35534
Product Name :
pLenti 4.1 Ex miR200c-141
article :
| doi | 10.1038/ncb1722 |
| id | 5145 |
| pubmed_id | 18376396 |
bacterial resistance :
Ampicillin
cloning :
| backbone | pLenti 4.1Ex | ||
| backbone_mutation | |||
| backbone_origin | Scott Hammond | ||
| backbone_size | 8749 | ||
| promoter | |||
| sequencing_primer_3 | |||
| sequencing_primer_5 | |||
| vector_types |
|
growth strain :
3rd generation lentiviral vector
origin :
37
pi :
|
resistance markers :
| 1220 |
tags :
Unknown
terms :
| Puromycin |
company information
Addgene
490 Arsenal Way, Suite 100
Watertown, MA 02472
Watertown, MA 02472
info@addgene.org
https://www.addgene.org617.225.9000
headquarters: USA
questions and comments
